4//SEC Filing
Deniger Drew 4
Accession 0000899243-23-008999
CIK 0001107421other
Filed
Mar 16, 8:00 PM ET
Accepted
Mar 17, 8:30 PM ET
Size
5.6 KB
Accession
0000899243-23-008999
Insider Transaction Report
Form 4
Deniger Drew
VP, Research and Development
Transactions
- Award
Employee Stock Option (right to buy)
2023-03-15+125,000→ 125,000 totalExercise: $0.50Exp: 2033-03-14→ Common Stock (125,000 underlying)
Footnotes (1)
- [F1]One-sixteenth of the shares underlying the option vest in equal quarterly installments measured from March 15, 2023, with the first vesting occuring on June 15, 2023, subject to the Reporting Person's continued service through each such date.
Documents
Issuer
Alaunos Therapeutics, Inc.
CIK 0001107421
Entity typeother
Related Parties
1- filerCIK 0001921961
Filing Metadata
- Form type
- 4
- Filed
- Mar 16, 8:00 PM ET
- Accepted
- Mar 17, 8:30 PM ET
- Size
- 5.6 KB